The long-term trend of the EPS is a vital number as it helps understand the future potential of Aethlon Medical. It is usually expressed as a percentage and is then referred to as the EPS growth rate, which at this time is unavialble, but historically the EPS change was 42.86% over the last twelve months. Growth in EPS is an important measure of administration performance because it shows how much money Aethlon Medical is making for it’s investors or shareholders.



Aethlon Medical is in the computer hardware industry and is part of the technology sector. The company CEO is Timothy C. Rodell. Aethlon Medical Inc is a medical technology company. It operates through two segments namely Aethlon for therapeutic applications and ESI for diagnostic applications.

Previous Intraday Performance:

The AEMD shares had a previous change of -3.55% which opened at 1.42 and closed at 1.36. It moved to an intraday high of 1.43 and a low of 1.35.

SeekingAlpha:  Microcaps mostly among tech movers

Historical Performance:

Over the last five trading days, AEMD shares returned -9.93% and in the past 30 trading days it returned -2.86%. Over three months, it changed 19.30%. In one year it has changed -1.45% and within that year its 52-week high was 2.04 and its 52-week low was 0.82. AEMD stock is 65.53% above its 52 Week Low.

Our calculations result in a 200 day moving average of 1.23 and a 50 day moving average of 1.28. Right now, AEMD stock is trading 10.17% above its 200 day moving average.

SeekingAlpha:  Microcaps mostly among tech movers

Liquidity:

The company has a market cap of $24.9m with 18.3m shares outstanding and a float of 15.4m shares. Trading volume was 88,600 shares and has experienced an average volume of 606,320 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.

Earnings:

The last annual reported EPS for Aethlon Medical was -0.49 which ended on 31st of March 2018. Based on 2 analyst estimates, the consensus EPS for the next quarter is -0.10.

Below was the last reported quarterly earnings per share:
09-30-2018:  -0.08
06-30-2018:  -0.06
03-31-2018:  -0.06
12-31-2017:  -0.08

Indicators Also to Watch:

Based on the latest filings, there is 17.70% of insider ownership and 8.40% of institutional ownership. Short-interest was 0, which was 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.00.



I calculated the beta to be 1.22

PR Newswire:  BMO Financial Group Announces New Financial Crimes Unit to be Headed by Larry Zelvin

Fundamental Numbers:

Based on last reported financials, the company’s return on equity is -239.51%, return on assets is -158.09%, price-to-sales is 115.10 and price-to-book is 6.04.

Company Score Card:

Results are out of six:
 2  : Growth Expectations Result
 6  : Financial Safety Result
 0  : Past Performance Result
 0  : Valuation Result
 0  : Dividend Safety Result
 2  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).

LEAVE A REPLY

Please enter your comment!
Please enter your name here